The revised Common Rule, also known as the 2018 Common Rule, was finalized in January 2017 and fully implemented as of January 21, 2019, updating protections for human subjects in federally funded research.
When was the Common Rule updated?
The Common Rule was most recently updated on January 18, 2017, when the U.S. Department of Health and Human Services and 15 other federal departments announced revisions to the policy.
You’ll find the final rule in the Federal Register the very next day. Compliance kicked in on January 21, 2019, though some parts—like consent tweaks and single IRB review—rolled out more slowly.
What is the current status of the Common Rule?
As of January 21, 2019, the revised Common Rule is fully in effect in the United States, replacing earlier versions that had been in place since 1991.
HHS gave institutions extra breathing room after pushing the original July 2018 deadline back by six months. During that gap, the 1991 rules still applied—no mad dash, no panic.
What is revised Common Rule?
The revised Common Rule introduces new requirements for clinical trials, including mandatory posting of consent forms on a federal website within a specific timeframe after research begins.
It also widens the exempt categories for low-risk work, speeds up IRB reviews by letting one board handle cooperative studies, and tightens consent practices. The whole point? Keep oversight modern while keeping participants safe.
What is the US Common Rule?
The US Common Rule is the set of federal regulations governing human subjects research across 16 federal departments and agencies, including HHS, NIH, and the VA.
It covers every study that touches human participants and gets federal money—or is regulated by these agencies. Even non-federally funded outfits often adopt it to stay consistent and earn public trust.
Who does the Common Rule protect?
The Common Rule protects all individuals involved in human subjects research, including vulnerable populations such as pregnant women, fetuses, neonates, prisoners, and children.
Subpart A sets the baseline. Then Subparts B, C, and D pile on extra safeguards for specific groups. And yes, these protections kick in whether the study has a federal check or not.
What is 45 CFR 46 Subpart A?
45 CFR 46 Subpart A is the foundational regulation known as the Common Rule, outlining ethical standards and protections for human research participants.
It spells out consent rules, IRB makeup and duties, and what research can even get approved. This is the rulebook for virtually every federally funded human study in the country.
What leads to Common Rule?
The Common Rule was developed in response to a 1981 recommendation by the President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, which called for uniform standards across federal agencies.
Those recommendations borrowed from earlier HHS rules and aimed for consistency. After a decade of fine-tuning, the policy landed in 1991.
Why is the Common Rule important?
The Common Rule is important because it establishes core procedures for protecting human research participants, including requirements for informed consent and review by an Institutional Review Board (IRB).
It forces clear communication about risks and benefits, keeps participants’ rights front and center, and—honestly—this is the best approach for maintaining public confidence in science and medicine.
Do scientists have the right to use cells from a person’s body without his her knowledge?
No, scientists generally cannot use identifiable cells or tissues from a person without consent, but anonymized biospecimens (with identity removed) may be used without consent under certain conditions.
Under the revised rule, identifiable private info or biospecimens need consent unless they’re fully de-identified or fit an exemption. (Remember Henrietta Lacks? That’s why the rules tightened.) Today, researchers must follow strict ethical and regulatory guardrails.
What does 45 CFR stand for?
45 CFR stands for Title 45 of the Code of Federal Regulations, which governs public welfare in the United States.
Within that title, Part 46 specifically covers human-subject protections. The CFR is basically the government’s official playbook—updated every year and organized by topic.
What is the Common Rule informed consent?
The Common Rule informed consent process must provide clear, understandable information about the research, including its purpose, risks, benefits, alternatives, and data use, to allow participants to make informed decisions.
Consent forms should read like plain English, not legalese. IRBs keep an eye on this to make sure the process is truly ethical.
What is broad consent?
Broad consent allows researchers to store and use identifiable biospecimens or data for future research without obtaining additional specific consent, provided the future use falls within the scope originally described.
Introduced in the 2018 update, it gives researchers flexibility while still respecting participants’ initial choices. IRB approval and proper documentation are musts.
What is exempt determination?
Exempt determination applies to research involving human subjects that qualifies for one of six exempt categories, such as educational settings or benign behavioral interventions.
Even low-risk studies need IRB sign-off to confirm they’re truly exempt. The payoff? Less paperwork without cutting corners on ethics.
How does the Common Rule define a human subject?
The Common Rule defines a human subject as a living individual about whom an investigator obtains identifiable private information or identifiable biospecimens for research purposes.
That includes data gathered through interaction or intervention, or identifiable info pulled from private sources. The key word is “identifiable”—it’s what triggers the protections.
What is the Common Rule law?
The Common Rule law is formally known as "The Federal Policy for the Protection of Human Subjects", adopted by multiple federal agencies in 1991 and revised in 2017.
You’ll find it mainly in 45 CFR 46 Subpart A. It’s the shared promise across federal agencies to keep research ethical and participants safe.
